Form 4: Scotts Miracle-Gro Director Nick Miaritis Reports Acquisition of Dividend Equivalent Rights

Sentiment:

SEC Form 4 Filing


Director Nick Miaritis reports acquiring 31 dividend equivalent rights related to Scotts Miracle-Gro common shares on March 7, 2025.

Summary

  • On March 7, 2025, Nick Miaritis, a director of Scotts Miracle-Gro Co., acquired 31 dividend equivalent rights.
  • These rights are associated with previously granted Deferred Stock Units (DSUs) or Restricted Stock Units (RSUs).
  • The dividend equivalent rights become exercisable proportionally with the DSUs or RSUs to which they relate.
  • Each dividend equivalent right represents the economic equivalent of one common share of Scotts Miracle-Gro.
  • The price of each dividend equivalent right is $62.18.
  • Following the transaction, Miaritis directly owns 31 dividend equivalent rights.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing, reporting a standard transaction. It doesn't convey any particularly positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure related to insider transactions, providing transparency to investors regarding the holdings and transactions of company directors. It reflects standard corporate governance practices.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading activities.
  • Companies like Home Depot (HD) and Lowe's (LOW), which operate in related industries, also have similar reporting requirements for their executives and directors.
  • The acquisition of dividend equivalent rights is a common form of executive compensation, aligning the interests of management with those of shareholders.

Stakeholder Impact

  • The transaction has a minimal direct impact on stakeholders.
  • It provides transparency to shareholders regarding director compensation and alignment of interests.

Key Dates

DateDescription
03/07/2025Date of transaction: Nick Miaritis acquired 31 dividend equivalent rights.
03/11/2025Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.